Katherine Y Wu1, Erik A Jensen2, Ammie M White3, Yan Wang4, David M Biko3, Kathleen Nilan1, María V Fraga2, Laura Mercer-Rosa4, Huayan Zhang2,5, Haresh Kirpalani2. 1. Department of Pediatrics. 2. Division of Neonatology. 3. Department of Radiology, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania; and. 4. Division of Pediatric Cardiology, Department of Pediatrics, and. 5. Division of Neonatology and Center for Newborn Care, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Abstract
Rationale: Bronchopulmonary dysplasia (BPD) is a heterogenous condition with poorly characterized disease subgroups. Objectives: To define the frequency of three disease components: moderate-severe parenchymal disease, pulmonary hypertension (PH), or large airway disease, in a referral cohort of preterm infants with severe BPD. The association between each component and a primary composite outcome of death before hospital discharge, tracheostomy, or home pulmonary vasodilator therapy was assessed. Methods: This was a retrospective, single-center cohort study of infants born at <32 weeks' gestation with severe BPD who underwent both chest computed tomography with angiography (CTA) and echocardiography between 40 and 50 weeks postmenstrual age between 2011 and 2015. Moderate-severe parenchymal lung disease was defined as an Ochiai score ≥8 on CTA. PH was diagnosed by echocardiogram using standard criteria. Large airway disease was defined as tracheomalacia or bronchomalacia on bronchoscopy and/or tracheoscopy or CTA.Measurements and Main Results: Of 76 evaluated infants, 73 (96%) were classifiable into phenotypic subgroups: 57 with moderate-severe parenchymal disease, 48 with PH, and 44 with large airway disease. The presence of all three disease components was most common (n = 23). Individually, PH and large airway disease, but not moderate-severe parenchymal disease, were associated with increased risk for the primary study outcome. Having more disease components was associated with an incremental increase in the risk for the primary outcome (2 vs. 1: odds ratio, 4.9; 95% confidence interval, 1.4-17.2 and 3 vs. 1: odds ratio, 12.8; 95% confidence interval, 2.4-70.0).Conclusions: Infants with severe BPD are variable in their predominant pathophysiology. Disease phenotyping may enable better risk stratification and targeted therapeutic intervention.
Rationale: Bronchopulmonary dysplasia (BPD) is a heterogenous condition with poorly characterized disease subgroups. Objectives: To define the frequency of three disease components: moderate-severe parenchymal disease, pulmonary hypertension (PH), or large airway disease, in a referral cohort of preterm infants with severe BPD. The association between each component and a primary composite outcome of death before hospital discharge, tracheostomy, or home pulmonary vasodilator therapy was assessed. Methods: This was a retrospective, single-center cohort study of infants born at <32 weeks' gestation with severe BPD who underwent both chest computed tomography with angiography (CTA) and echocardiography between 40 and 50 weeks postmenstrual age between 2011 and 2015. Moderate-severe parenchymal lung disease was defined as an Ochiai score ≥8 on CTA. PH was diagnosed by echocardiogram using standard criteria. Large airway disease was defined as tracheomalacia or bronchomalacia on bronchoscopy and/or tracheoscopy or CTA.Measurements and Main Results: Of 76 evaluated infants, 73 (96%) were classifiable into phenotypic subgroups: 57 with moderate-severe parenchymal disease, 48 with PH, and 44 with large airway disease. The presence of all three disease components was most common (n = 23). Individually, PH and large airway disease, but not moderate-severe parenchymal disease, were associated with increased risk for the primary study outcome. Having more disease components was associated with an incremental increase in the risk for the primary outcome (2 vs. 1: odds ratio, 4.9; 95% confidence interval, 1.4-17.2 and 3 vs. 1: odds ratio, 12.8; 95% confidence interval, 2.4-70.0).Conclusions: Infants with severe BPD are variable in their predominant pathophysiology. Disease phenotyping may enable better risk stratification and targeted therapeutic intervention.
Authors: Edward G Shepherd; Brian J Clouse; Kathryn A Hasenstab; Swetha Sitaram; Daniel T Malleske; Leif D Nelin; Sudarshan R Jadcherla Journal: Pediatrics Date: 2018-04-05 Impact factor: 7.124
Authors: María Álvarez-Fuente; Luis Arruza; Marta Muro; Carlos Zozaya; Alejandro Avila; Paloma López-Ortego; Carmen González-Armengod; Alba Torrent; Jose Luis Gavilán; María Jesús Del Cerro Journal: Eur J Pediatr Date: 2017-09-09 Impact factor: 3.183
Authors: Nara S Higano; David R Spielberg; Robert J Fleck; Andrew H Schapiro; Laura L Walkup; Andrew D Hahn; Jean A Tkach; Paul S Kingma; Stephanie L Merhar; Sean B Fain; Jason C Woods Journal: Am J Respir Crit Care Med Date: 2018-11-15 Impact factor: 30.528
Authors: Cristina Ramos-Navarro; Elena Maderuelo-Rodríguez; Ana Concheiro-Guisán; Santiago Pérez-Tarazona; Santiago Rueda-Esteban; Ana Sánchez-Torres; Manuel Sánchez-Solís; Ester Sanz-López; Manuel Sánchez-Luna Journal: Eur J Pediatr Date: 2021-10-01 Impact factor: 3.183
Authors: Erick Forno; Steven H Abman; Jagdev Singh; Mary E Robbins; Hiran Selvadurai; Paul T Schumacker; Paul D Robinson Journal: Am J Respir Crit Care Med Date: 2021-08-01 Impact factor: 30.528